平安医药及医疗器械创新ETF(516820)资产配置
序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
1 |
2025-03-31 |
97.63 |
- |
2.73 |
1,728,206,786.34 |
2 |
2024-12-31 |
97.64 |
- |
2.79 |
1,660,564,009.48 |
3 |
2024-09-30 |
96.45 |
- |
4.55 |
1,433,141,047.84 |
4 |
2024-06-30 |
94.53 |
- |
5.60 |
1,171,685,801.53 |
5 |
2024-03-31 |
96.89 |
- |
3.11 |
1,132,182,149.65 |
6 |
2023-12-31 |
97.80 |
- |
2.43 |
1,225,658,340.37 |
7 |
2023-09-30 |
98.35 |
- |
0.86 |
1,312,205,436.32 |
8 |
2023-06-30 |
98.98 |
- |
1.25 |
1,200,797,079.45 |
9 |
2023-03-31 |
98.62 |
- |
1.61 |
919,735,983.57 |
10 |
2022-12-31 |
98.72 |
- |
1.45 |
835,202,511.04 |
11 |
2022-09-30 |
98.24 |
- |
1.98 |
841,508,956.79 |
12 |
2022-06-30 |
98.74 |
- |
1.36 |
814,266,253.95 |
13 |
2022-03-31 |
99.26 |
- |
0.25 |
831,880,657.00 |
14 |
2021-12-31 |
99.05 |
- |
1.87 |
927,169,159.91 |
15 |
2021-09-30 |
99.17 |
- |
1.17 |
898,303,958.88 |